Evaluating antibody response pattern in asymptomatic virus infected pregnant females: Human well-being study

[Display omitted] The ongoing SARS-CoV-2 pandemic infecting millions of people globally has given rise to serious public health threats. The need for early detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in asymptomatic pregnant women is compelling to detect vertical transm...

Full description

Saved in:
Bibliographic Details
Published inJournal of King Saud University. Science Vol. 33; no. 1; p. 101255
Main Authors Ali, Ashaq, Rashid, Zubia, Zhou, Jieqiong, Zubair Yousaf, Muhammad, Galani, Saddia, Ashraf, Asma, Al-Ghanim, Khalid A., Al-Suliman, Emin, Ahmed, Zubair, Farooq, Muhammad, Virik, Promy, Kaimkhani, Z.A., Al-Mulhm, Norah, Mahboob, Shahid, Dong, Men, Huang, Qiuxiang
Format Journal Article
LanguageEnglish
Published Saudi Arabia Elsevier B.V 01.01.2021
The Author(s). Published by Elsevier B.V. on behalf of King Saud University
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:[Display omitted] The ongoing SARS-CoV-2 pandemic infecting millions of people globally has given rise to serious public health threats. The need for early detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in asymptomatic pregnant women is compelling to detect vertical transmission timely. Here, 11 SARS-CoV-2 asymptomatic pregnant cases from Wuhan China were investigated. All the patients were initially tested negative for SARS-CoV-2 on RT-PCR, so a chest CT scan was performed. Also, serum antibody (IgM and IgG) titers were estimated. CT scan of patients revealed typical abnormalities related to SARS-CoV-2, indicating ground-glass opacity and infection lesions suggesting viral pneumonia. Elevated IgM and IgG antibodies levels (p < 0.001) were also noticed in infected patients. Hence, CT imaging and serum antibody response are valuable in the early detection of SARS-CoV-2 in asymptomatic pregnant patients. These might serve as prognostic markers for healthcare professionals, in RT-PCR negative patients, to assess the effect of given treatment by chest CT.
ISSN:1018-3647
2213-686X
DOI:10.1016/j.jksus.2020.101255